Green Cross Corporation received US FDA certification for biological plant

Published: 2008-01-15 06:58:00

Updated: 2008-01-15 06:58:00

Green Cross Corporation said it has received a written certification on the design of its biological plant at Ochang of North Chungcheng Province, from the U.S. Food and Drug Administration at the end of last month.

According to the company, the US FDA held a design review meeting on December...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK